Literature DB >> 12357010

Motor neurone disease.

K Talbot1.   

Abstract

Motor neurone disease (MND), or amyotrophic lateral sclerosis (ALS), is a neurodegenerative disorder of unknown aetiology. Progressive motor weakness and bulbar dysfunction lead to premature death, usually from respiratory failure. Confirming the diagnosis may initially be difficult until the full clinical features are manifest. For all forms of the disease there is a significant differential diagnosis to consider, including treatable conditions, and therefore specialist neurological opinion should always be sought. Clear genetic inheritance has been demonstrated in a minority of patients with familial ALS but elucidation of the biological basis of genetic subtypes is also providing important information which may lead to treatments for sporadic forms of the disease. In the absence of curative or disease modifying therapy, management is supportive and requires a multidisciplinary approach. If, as seems likely, complex inherited and environmental factors contribute to the pathogenesis of MND, future treatment may involve a combination of molecular based treatments or restoration of cellular integrity using stem cell grafts.

Entities:  

Mesh:

Year:  2002        PMID: 12357010      PMCID: PMC1742493          DOI: 10.1136/pmj.78.923.513

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  42 in total

1.  A prospective study of quality of life in ALS patients treated with noninvasive ventilation.

Authors:  R A Lyall; N Donaldson; T Fleming; C Wood; I Newsom-Davis; M I Polkey; P N Leigh; J Moxham
Journal:  Neurology       Date:  2001-07-10       Impact factor: 9.910

Review 2.  Clinical trials in ALS: an overview.

Authors:  M R Turner; M J Parton; P N Leigh
Journal:  Semin Neurol       Date:  2001-06       Impact factor: 3.420

Review 3.  Does primary lateral sclerosis exist? A study of 20 patients and a review of the literature.

Authors:  N Le Forestier; T Maisonobe; A Piquard; S Rivaud; L Crevier-Buchman; F Salachas; P F Pradat; L Lacomblez; V Meininger
Journal:  Brain       Date:  2001-10       Impact factor: 13.501

4.  Juvenile muscular atrophy of unilateral upper extremity.

Authors:  K HIRAYAMA; T TSUBAKI; Y TOYOKURA; S OKINAKA
Journal:  Neurology       Date:  1963-05       Impact factor: 9.910

Review 5.  Spinal muscular atrophy.

Authors:  K Talbot; K E Davies
Journal:  Semin Neurol       Date:  2001-06       Impact factor: 3.420

6.  Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.

Authors:  K Grohmann; M Schuelke; A Diers; K Hoffmann; B Lucke; C Adams; E Bertini; H Leonhardt-Horti; F Muntoni; R Ouvrier; A Pfeufer; R Rossi; L Van Maldergem; J M Wilmshurst; T F Wienker; M Sendtner; S Rudnik-Schöneborn; K Zerres; C Hübner
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

Review 7.  Molecular mechanisms in spinal muscular atrophy: models and perspectives.

Authors:  M Sendtner
Journal:  Curr Opin Neurol       Date:  2001-10       Impact factor: 5.710

8.  Motor neuron disease after electric injury.

Authors:  H Jafari; P Couratier; W Camu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-08       Impact factor: 10.154

9.  Inclusion body myositis mimicking motor neuron disease.

Authors:  R Dabby; D J Lange; W Trojaborg; A P Hays; R E Lovelace; T H Brannagan; L P Rowland
Journal:  Arch Neurol       Date:  2001-08

10.  Linkage of familial amyotrophic lateral sclerosis with frontotemporal dementia to chromosome 9q21-q22.

Authors:  B A Hosler; T Siddique; P C Sapp; W Sailor; M C Huang; A Hossain; J R Daube; M Nance; C Fan; J Kaplan; W Y Hung; D McKenna-Yasek; J L Haines; M A Pericak-Vance; H R Horvitz; R H Brown
Journal:  JAMA       Date:  2000-10-04       Impact factor: 56.272

View more
  21 in total

1.  Denaturing high performance liquid chromatography: high throughput mutation screening in familial hypertrophic cardiomyopathy and SNP genotyping in motor neurone disease.

Authors:  B Yu; N A Sawyer; M Caramins; Z G Yuan; R B Saunderson; R Pamphlett; D R Richmond; R W Jeremy; R J Trent
Journal:  J Clin Pathol       Date:  2005-05       Impact factor: 3.411

Review 2.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

3.  Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.

Authors:  F Agosta; E Pagani; M A Rocca; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

Review 4.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

5.  Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis.

Authors:  P Valsasina; F Agosta; B Benedetti; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-10-09       Impact factor: 10.154

6.  The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.

Authors:  Burkhard Schütz; Jens Reimann; Lucia Dumitrescu-Ozimek; Karin Kappes-Horn; Gary E Landreth; Britta Schürmann; Andreas Zimmer; Michael T Heneka
Journal:  J Neurosci       Date:  2005-08-24       Impact factor: 6.167

Review 7.  Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders.

Authors:  Mirza Ali Mofazzal Jahromi; Amir Abdoli; Mohammad Rahmanian; Hassan Bardania; Mehrdad Bayandori; Seyed Masoud Moosavi Basri; Alireza Kalbasi; Amir Reza Aref; Mahdi Karimi; Michael R Hamblin
Journal:  Mol Neurobiol       Date:  2019-07-01       Impact factor: 5.590

Review 8.  Innate immune activation in neurodegenerative disease.

Authors:  Michael T Heneka; Markus P Kummer; Eicke Latz
Journal:  Nat Rev Immunol       Date:  2014-07       Impact factor: 53.106

9.  An animal model of oral dysphagia in amyotrophic lateral sclerosis.

Authors:  Teresa E Lever; Ambre Gorsek; Kathleen T Cox; Kevin F O'Brien; Norman F Capra; Monica S Hough; Alexander K Murashov
Journal:  Dysphagia       Date:  2008-12-24       Impact factor: 3.438

10.  hVAPB, the causative gene of a heterogeneous group of motor neuron diseases in humans, is functionally interchangeable with its Drosophila homologue DVAP-33A at the neuromuscular junction.

Authors:  Andrea Chai; James Withers; Young Ho Koh; Katherine Parry; Hong Bao; Bing Zhang; Vivian Budnik; Giuseppa Pennetta
Journal:  Hum Mol Genet       Date:  2007-10-18       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.